Meridian Bioscience Archives | Be Korea-savvy
New Testing Procedure Holds Promise as a Critical Tool in the Global Effort to Eliminate Malaria

New Testing Procedure Holds Promise as a Critical Tool in the Global Effort to Eliminate Malaria

CINCINNATI, Apr. 24 (Korea Bizwire) — As the global community gathers for World Malaria Day to celebrate successes and plot strategy to eliminate the disease from the face of the earth, a new ray of hope is emerging from a surprising place: the testing side of the equation. Meridian Bioscience, Inc. of Cincinnati, Ohio (NASDAQ:VIVO) [...]

Bioline Launches New JetSeq DNA Quantification Kits

Bioline Launches New JetSeq DNA Quantification Kits

CINCINNATI, Mar. 27 (Korea Bizwire) — Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the further expansion of the JetSeq™ portfolio for Next Generation Sequencing (NGS) sample preparation. The new JetSeq™ Library Quantification Kit is a qPCR-based assay that provides fast, accurate and sensitive quantification of adaptor-ligated DNA fragments [...]

Bioline Launches New JetSeq™ DNA Library Preparation Kits

Bioline Launches New JetSeq™ DNA Library Preparation Kits

CINCINNATI, Feb. 8 (Korea Bizwire) — Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the expansion of the JetSeq™ DNA Library Preparation portfolio for Next Generation Sequencing (NGS) sample preparation. Developed in collaboration with Oxford Gene Technology (OGT), the new JetSeq™ DNA Library Preparation Kits use pre-optimized buffers to [...]

Meridian Bioscience Announces the Launch of TruQuick™ Rapid Tests for Asia Pacific

Meridian Bioscience Announces the Launch of TruQuick™ Rapid Tests for Asia Pacific

CINCINNATI, Feb. 3 (Korea Bizwire) — Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the launch of TruQuick™, a comprehensive point-of-care product menu of rapid tests for the diagnosis of tropical, infectious, sexually transmitted, respiratory, gastrointestinal, cancer, and cardiac diseases. This product menu will enable Meridian to rapidly expand its product portfolio of high value rapid tests [...]

Bioline Launches the Full Range of EPIK™ miRNA Assays

Bioline Launches the Full Range of EPIK™ miRNA Assays

CINCINNATI, Jan. 9 (Korea Bizwire) — Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the expansion of the EPIK™ miRNA Select Assays, originally developed for the study of individual microRNA (miRNA) molecules. In collaboration with MiRXES, Bioline released 800 EPIK™ miRNA Select Assays in March 2016 and this has [...]

Bioline is Certified to the ISO 13485 Quality Standard

Bioline is Certified to the ISO 13485 Quality Standard

CINCINNATI, Oct. 3 (Korea Bizwire) — Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO) is proud to announce that the London R&D and Berlin manufacturing facilities are now fully accredited to the ISO 13485 quality standard. Bioline recognizes the importance of adhering to a quality management system in the development, manufacture [...]

Bioline Launches New SensiFAST™ Lyo-Ready No-ROX Mix

Bioline Launches New SensiFAST™ Lyo-Ready No-ROX Mix

CINCINNATI, Sept. 20 (Korea Bizwire) — Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide release of the SensiFAST Lyo-Ready No-ROX Mix from Bioline to add to the SensiFAST family of real-time PCR products. Bioline has developed a ready-to-use, lyophilization-compatible qPCR mix, the SensiFAST Lyo-Ready No-ROX [...]

Meridian Malaria Test Wins Prestigious Innovation Award

Meridian Malaria Test Wins Prestigious Innovation Award

CINCINNATI, Aug. 30 (Korea Bizwire) — Meridian Bioscience, Inc. (NASDAQ:VIVO) was awarded 1st place for innovation in emergency treatment and point-of-care testing for its illumigene® Malaria test at the 2016 JIB/ACNBH Conference this summer. Innovations from worldwide companies contributing to the development of the Medical Biology industry were put under the spotlight at this year’s [...]

New Malaria Test, illumigene® Malaria, Sets a New Gold Standard for Diagnosis

New Malaria Test, illumigene® Malaria, Sets a New Gold Standard for Diagnosis

CINCINNATI, Jan. 26 (Korea Bizwire) — Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has received the CE Mark for illumigene® Malaria, a novel, highly accurate  test developed by Meridian with the technical assistance of the Centers for Disease Control and Prevention (CDC) and Cheikh Anta Diop University of Dakar, Senegal. The test is up to 80,000 [...]